| Product NDC: | 12634-437 |
| Proprietary Name: | CARISOPRODOL |
| Non Proprietary Name: | CARISOPRODOL |
| Active Ingredient(s): | 350 mg/1 & nbsp; CARISOPRODOL |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 12634-437 |
| Labeler Name: | Apotheca, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA089346 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20100210 |
| Package NDC: | 12634-437-79 |
| Package Description: | 25 TABLET in 1 BOTTLE (12634-437-79) |
| NDC Code | 12634-437-79 |
| Proprietary Name | CARISOPRODOL |
| Package Description | 25 TABLET in 1 BOTTLE (12634-437-79) |
| Product NDC | 12634-437 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | CARISOPRODOL |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20100210 |
| Marketing Category Name | ANDA |
| Labeler Name | Apotheca, Inc. |
| Substance Name | CARISOPRODOL |
| Strength Number | 350 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Centrally-mediated Muscle Relaxation [PE],Muscle Relaxant [EPC] |